130 related articles for article (PubMed ID: 7505366)
1. Sodium nitroprusside, an endothelium-derived relaxing factor congener, increases platelet cyclic GMP levels and inhibits epinephrine-exacerbated in vivo platelet thrombus formation in stenosed canine coronary arteries.
Rovin JD; Stamler JS; Loscalzo J; Folts JD
J Cardiovasc Pharmacol; 1993 Oct; 22(4):626-31. PubMed ID: 7505366
[TBL] [Abstract][Full Text] [Related]
2. Effect of aspirin and epinephrine on experimentally induced thrombogenesis in dogs. A parallelism between in vivo and ex vivo thrombosis models.
Roux SP; Sakariassen KS; Turitto VT; Baumgartner HR
Arterioscler Thromb; 1991; 11(5):1182-91. PubMed ID: 1911705
[TBL] [Abstract][Full Text] [Related]
3. Epinephrine potentiation of in vivo stimuli reverses aspirin inhibition of platelet thrombus formation in stenosed canine coronary arteries.
Folts JD; Rowe GG
Thromb Res; 1988 May; 50(4):507-16. PubMed ID: 3413717
[TBL] [Abstract][Full Text] [Related]
4. Localized administration of sodium nitroprusside enhances its protection against platelet aggregation in stenosed and injured coronary arteries.
Willerson JT; Igo SR; Yao SK; Ober JC; Macris MP; Ferguson JJ
Tex Heart Inst J; 1996; 23(1):1-8. PubMed ID: 8680268
[TBL] [Abstract][Full Text] [Related]
5. Effects of trimetazidine on in vivo coronary arterial platelet thrombosis.
Belcher PR; Drake-Holland AJ; Hynd JW; Noble MI
Cardiovasc Drugs Ther; 1993 Feb; 7(1):149-57. PubMed ID: 8485070
[TBL] [Abstract][Full Text] [Related]
6. Administration of wine and grape juice inhibits in vivo platelet activity and thrombosis in stenosed canine coronary arteries.
Demrow HS; Slane PR; Folts JD
Circulation; 1995 Feb; 91(4):1182-8. PubMed ID: 7850957
[TBL] [Abstract][Full Text] [Related]
7. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
[TBL] [Abstract][Full Text] [Related]
8. High-dose droperidol protects against experimental coronary thrombosis in dogs and pigs and attenuates aggregation of porcine platelets and Ca2+ mobilization in human platelets.
Bertha BG; Sill JC; Berger I; Folts JD; Milde JH
Anesthesiology; 1993 Apr; 78(4):733-43. PubMed ID: 8466073
[TBL] [Abstract][Full Text] [Related]
9. Combined inhibitory effects of aspirin and ethanol on adrenaline exacerbation of acute platelet thrombus formation in stenosed canine coronary arteries.
Keller JW; Folts JD
Cardiovasc Res; 1990 Mar; 24(3):191-7. PubMed ID: 2346953
[TBL] [Abstract][Full Text] [Related]
10. Tocotrienols-induced inhibition of platelet thrombus formation and platelet aggregation in stenosed canine coronary arteries.
Qureshi AA; Karpen CW; Qureshi N; Papasian CJ; Morrison DC; Folts JD
Lipids Health Dis; 2011 Apr; 10():58. PubMed ID: 21489303
[TBL] [Abstract][Full Text] [Related]
11. Effects of MDL 28,133A, a 5-HT2 receptor antagonist, on platelet aggregation and coronary thrombosis in dogs.
Hsieh CP; Sakai K; Bruns GC; Dage RC
J Cardiovasc Pharmacol; 1994 Nov; 24(5):761-72. PubMed ID: 7532754
[TBL] [Abstract][Full Text] [Related]
12. An in vivo model of experimental arterial stenosis, intimal damage, and periodic thrombosis.
Folts J
Circulation; 1991 Jun; 83(6 Suppl):IV3-14. PubMed ID: 2040070
[TBL] [Abstract][Full Text] [Related]
13. The snake venom peptide sarafotoxin S6b inhibits repetitive platelet thrombus formation in the stenosed canine coronary artery.
Leadley RJ; Lee P; Erickson LA; Shebuski RJ
J Cardiovasc Pharmacol; 1993; 22 Suppl 8():S199-203. PubMed ID: 7509944
[TBL] [Abstract][Full Text] [Related]
14. Aurintricarboxylic acid in a canine model of coronary artery thrombosis.
Strony J; Phillips M; Brands D; Moake J; Adelman B
Circulation; 1990 Mar; 81(3):1106-14. PubMed ID: 2306818
[TBL] [Abstract][Full Text] [Related]
15. Halothane, but not isoflurane or enflurane, protects against spontaneous and epinephrine-exacerbated acute thrombus formation in stenosed dog coronary arteries.
Bertha BG; Folts JD; Nugent M; Rusy BF
Anesthesiology; 1989 Jul; 71(1):96-102. PubMed ID: 2751146
[TBL] [Abstract][Full Text] [Related]
16. Redirection of arachidonic acid metabolism by ICI D1542: effects on thrombus formation in the coronary artery of the anaesthetized dog.
McAuliffe SJ; Moors JA; Snow HM; Wayne M; Jessup R
Br J Pharmacol; 1993 Apr; 108(4):901-6. PubMed ID: 8485629
[TBL] [Abstract][Full Text] [Related]
17. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: inhibition of cyclic AMP breakdown by cyclic GMP.
Maurice DH; Haslam RJ
Mol Pharmacol; 1990 May; 37(5):671-81. PubMed ID: 2160060
[TBL] [Abstract][Full Text] [Related]
18. Interaction between the effects of 5-hydroxytryptamine and adrenaline on the growth of platelet thrombi in the coronary artery of the anaesthetized dog.
McAuliffe SJ; Snow HM; Cox B; Smith CC; Noble MI
Br J Pharmacol; 1993 Jun; 109(2):405-10. PubMed ID: 8358542
[TBL] [Abstract][Full Text] [Related]
19. Inhibition by the combined Ca2+ and 5-HT2 receptor antagonist nexopamil (LU 49938) of intracoronary thrombus formation in a canine model of arterial stenosis and intimal damage.
Kirchengast M; Rübsamen K; Lehmann HD
J Cardiovasc Pharmacol; 1993 Nov; 22(5):687-94. PubMed ID: 7506319
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of epinephrine-exacerbated coronary thrombus formation by prostacyclin in the dog.
Bertha BG; Folts JD
J Lab Clin Med; 1984 Feb; 103(2):204-14. PubMed ID: 6363581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
